A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients.
about
Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticityEffects of Extracorporeal Shock Wave Therapy on Spasticity in Patients after Brain Injury: A Meta-analysisSystematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Lower Limb SpasticityGait training in hemiplegia.Recent advances in rehabilitation.Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.Botulinum toxin A (BoNT-A) for spasticity in adults. What is the evidence?Management of strokeQuality of the stroke rehabilitation research.Evaluating the role of botulinum toxin in the management of focal hypertonia in adults.Does reducing spasticity translate into functional benefit? An exploratory meta-analysis.Botulinum toxin in clinical practiceBotulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.Botulinum toxin in poststroke spasticityThe role of botulinum toxin injections in the management of muscle overactivity of the lower limb.Does the treatment of spastic equinovarus deformity following stroke with botulinum toxin increase gait velocity? A systematic review and meta-analysis.Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.Systematic review of the effectiveness of pharmacological interventions in the treatment of spasticity of the hemiparetic lower extremity more than six months post stroke.The efficacy of Botulinum Toxin A for spasticity and pain in adults: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach.Spasticity after stroke: physiology, assessment and treatment.The efficacy of Botulinum Toxin A on improving ease of care in the upper and lower limbs: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach.The efficacy of Botulinum Toxin A for limb spasticity on improving activity restriction and quality of life: a systematic review and meta-analysis using the GRADE approach.Effectiveness of Botulinum Toxin for Lower Limbs Spasticity after Stroke: A Systematic Review and Meta-Analysis.A randomized controlled trial of selective neurotomy versus botulinum toxin for spastic equinovarus foot after stroke.Determination of injection site in flexor digitorum longus for effective and safe botulinum toxin injection.Gait changes following botulinum toxin A treatment in stroke.The effect of transcranial direct current stimulation (tDCS) on locomotion and balance in patients with chronic stroke: study protocol for a randomised controlled trial.Early botulinum toxin treatment for spastic pes equinovarus--a randomized double-blind placebo-controlled study.Are gait and mobility measures responsive to change following botulinum toxin injections in adults with lower limb spasticity?Long-term treatment of spasticity with botulinum toxin type A: an analysis of 1221 treatments in 137 patients.Intramuscular pressure before and after botulinum toxin in chronic exertional compartment syndrome of the leg: a preliminary study.Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension.A systematic review: efficacy of botulinum toxin in walking and quality of life in post-stroke lower limb spasticity.Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury.New advances in botulinum toxin therapy for pain.Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on lower limb spasticity classified by spastic muscle echo intensity in post-stroke patients.Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.Non-surgical management of ankle contracture following acquired brain injury.Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on upper and lower limb spasticity in post-stroke patients.Effects of a 6-month self-rehabilitation programme in addition to botulinum toxin injections and conventional physiotherapy on limitations of patients with spastic hemiparesis following stroke (ADJU-TOX): protocol study for a randomised controlled, i
P2860
Q26750450-60D1EE42-4C0B-4DF4-9EBE-CB196A8B9371Q26824164-C569139E-66A5-4D0D-BC74-BCD45AF50DA9Q28074221-5DFC7E84-57AF-41B0-9CCB-84E02E1EC52CQ30540022-366E31BA-5EAA-4CDB-9C67-893DBCE2BB24Q33800982-AA947C5A-1C99-44D9-80C6-A87829DCC117Q34021279-4D598659-627E-4398-A4AA-4F14D16990BDQ34579725-9FBBADEF-C874-467A-999E-51273D05B6D4Q35075616-008779F9-ED52-4E07-BD1D-15268412B0AEQ35217428-7801F4C7-EDCF-40F8-BEE4-D7AACC9EF15CQ35459787-6CEE7775-0121-4F82-9AF4-C9D996B707CAQ35478000-21E15E9F-0723-4794-B2A4-5CE6D13CA156Q35807826-5EC22304-DF12-475B-8A39-C3399E901365Q36541635-FE3EC070-9D7B-466B-B567-DD04CAAC9FA9Q36868342-29B9ABC9-899E-420B-B5AC-1C702ECA32EFQ37011519-85A00495-FCFA-4734-A054-42F67D4AC43AQ37759065-377F4A7B-09FA-43F7-8EDE-B283C6655FCCQ37995787-186C4BE3-3FDA-4453-8159-56E9BFFA1EB9Q38063451-55ABDE69-D1EF-41A1-BD8A-5E38DC742C16Q38122349-29F0F22C-D51B-4036-AAE8-E85CF493BF32Q38124046-2466C797-C7E9-4672-9920-F2199EE72F49Q38263487-DE8EF1B7-7BD1-4E83-BDDD-73B4D8A7184AQ38543439-0924C22E-1062-4085-A91A-71698209DF08Q38808184-9FBF276D-F892-4A3C-81CF-C730E76FFC74Q39404024-03762C68-7397-451B-852B-48C368450EF6Q41969834-4151A16B-0E20-4512-9710-4FEEC792089FQ42639238-088675EA-E25F-4DDA-8403-58B8A365A089Q42643765-190B4F4D-8C68-4BE8-94BE-7782562C69ADQ42656165-1D180FD9-5E45-4BE8-AF84-C2FB3356C482Q44497245-D6A207B6-D795-4061-8D48-7F54BECC0F26Q44608563-C8B5E381-2EA1-44D5-82FC-94DD27FAC629Q44744182-3382733F-8B2F-42ED-991C-F66E12DFD134Q47107133-39AEEC80-2815-4999-9BEF-651F23F96C31Q47171933-376CA265-F436-45D4-A227-1A8F500C16AEQ48123385-09F585E0-3353-4FD9-8EAE-06A2A86141B7Q49021073-1A8BE24B-626B-420A-9565-A4F3847886B6Q49554112-03F0EE28-FE2A-4291-9106-4C596600506DQ51006989-A8AFCE3E-162E-416E-8A3B-F4A062ADFC67Q51660319-2051C9BD-6B9D-4848-9C90-42FD492DD3ACQ51723052-AFC64938-B0F7-4340-90AB-C839FD0DFC6BQ56515702-1CF9BFD8-EF00-428C-9E89-3D8AFDE6EF70
P2860
A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
A randomised, double blind, pl ...... foot in hemiparetic patients.
@en
type
label
A randomised, double blind, pl ...... foot in hemiparetic patients.
@en
prefLabel
A randomised, double blind, pl ...... foot in hemiparetic patients.
@en
P2093
P2860
P356
P1476
A randomised, double blind, pl ...... foot in hemiparetic patients.
@en
P2093
Debelleix X
P2860
P304
P356
10.1136/JNNP.61.3.265
P407
P577
1996-09-01T00:00:00Z